Skip to content

The effect of CD07813 in the transplant model of psoriasis; in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting activated peripheral blood cells intra-dermally into the transplant. RD/10/15700

The effect of CD07813 in the transplant model of psoriasis; in which a psoriatic lesion is induced in non-lesional skin transplanted onto immune-deficient (BNX) mice by injecting activated peripheral blood cells intra-dermally into the transplant. RD/10/15700 - The effect of CD07813 in the transplant model of psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35876
Enrollment
17
Registered
2011-03-09
Start date
2011-08-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Sponsors

Galderma
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with mild to moderate psoriasis vulgaris

Exclusion criteria

Exclusion criteria: Volunteers cannot be taking systemic drugs to treat their psoriasis, or immune-modulators for other diseases Volunteers cannot be undergoing UV/light therapy Volunteers should not show the Kobner phenomenon at wound sites.

Design outcomes

Primary

MeasureTime frame
N.A

Secondary

MeasureTime frame
N.A

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)